The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysisYa‐Nan Jin, Ji‐Jin Yao|Cancer Immunology Immunotherapy|2024Cited by 18